NeuroImage (Oct 2023)

Deep learning-assisted identification and quantification of aneurysmal subarachnoid hemorrhage in non-contrast CT scans: Development and external validation of Hybrid 2D/3D UNet

  • Ping Hu,
  • Haizhu Zhou,
  • Tengfeng Yan,
  • Hongping Miu,
  • Feng Xiao,
  • Xinyi Zhu,
  • Lei Shu,
  • Shuang Yang,
  • Ruiyun Jin,
  • Wenlei Dou,
  • Baoyu Ren,
  • Lizhen Zhu,
  • Wanrong Liu,
  • Yihan Zhang,
  • Kaisheng Zeng,
  • Minhua Ye,
  • Shigang Lv,
  • Miaojing Wu,
  • Gang Deng,
  • Rong Hu,
  • Renya Zhan,
  • Qianxue Chen,
  • Dong Zhang,
  • Xingen Zhu

Journal volume & issue
Vol. 279
p. 120321

Abstract

Read online

Accurate stroke assessment and consequent favorable clinical outcomes rely on the early identification and quantification of aneurysmal subarachnoid hemorrhage (aSAH) in non-contrast computed tomography (NCCT) images. However, hemorrhagic lesions can be complex and difficult to distinguish manually. To solve these problems, here we propose a novel Hybrid 2D/3D UNet deep-learning framework for automatic aSAH identification and quantification in NCCT images. We evaluated 1824 consecutive patients admitted with aSAH to four hospitals in China between June 2018 and May 2022. Accuracy and precision, Dice scores and intersection over union (IoU), and interclass correlation coefficients (ICC) were calculated to assess model performance, segmentation performance, and correlations between automatic and manual segmentation, respectively. A total of 1355 patients with aSAH were enrolled: 931, 101, 179, and 144 in four datasets, of whom 326 were scanned with Siemens, 640 with Philips, and 389 with GE Medical Systems scanners. Our proposed deep-learning method accurately identified (accuracies 0.993–0.999) and segmented (Dice scores 0.550–0.897) hemorrhage in both the internal and external datasets, even combinations of hemorrhage subtypes. We further developed a convenient AI-assisted platform based on our algorithm to assist clinical workflows, whose performance was comparable to manual measurements by experienced neurosurgeons (ICCs 0.815–0.957) but with greater efficiency and reduced cost. While this tool has not yet been prospectively tested in clinical practice, our innovative hybrid network algorithm and platform can accurately identify and quantify aSAH, paving the way for fast and cheap NCCT interpretation and a reliable AI-based approach to expedite clinical decision-making for aSAH patients.

Keywords